Dimensional Fund Advisors
DAWN

Dimensional Fund Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Dimensional Fund Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-819,371
Closed -$17.6M – 3250
2026
Q1 		$17.6M Sell
819,371
-217,941
-21% -$3.07M ﹤0.01% 2033
2025
Q4 		$9.67M Sell
1,037,312
-185,972
-15% -$1.55M ﹤0.01% 2295
2025
Q3 		$8.62M Sell
1,223,284
-193,269
-14% -$1.33M ﹤0.01% 2357
2025
Q2 		$9.21M Buy
1,416,553
+113,588
+9% +$781K ﹤0.01% 2308
2025
Q1 		$10.3M Buy
1,302,965
+375,948
+41% +$4.05M ﹤0.01% 2240
2024
Q4 		$11.7M Buy
927,017
+90,822
+11% +$1.26M ﹤0.01% 2244
2024
Q3 		$11.6M Sell
836,195
-51,922
-6% -$741K ﹤0.01% 2238
2024
Q2 		$12.2M Sell
888,117
-93,455
-10% -$1.37M ﹤0.01% 2174
2024
Q1 		$16.2M Buy
981,572
+203,655
+26% +$3.05M ﹤0.01% 2089
2023
Q4 		$11.4M Buy
777,917
+471,732
+154% +$5.72M ﹤0.01% 2264
2023
Q3 		$3.76M Buy
306,185
+123,007
+67% +$1.6M ﹤0.01% 2615
2023
Q2 		$2.19M Sell
183,178
-180,881
-50% -$2.36M ﹤0.01% 2756
2023
Q1 		$4.87M Buy
+364,059
New +$7.11M ﹤0.01% 2495
2022
Q3 		$1.03M Buy
+51,408
New +$1.09M ﹤0.01% 2873

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Dimensional Fund Advisors's DAWN Position: Q2 2026 in Review

Dimensional Fund Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 819,371 shares — an estimated $17.6M sold.

Dimensional Fund Advisors first reported a position in DAWN in Q3 2022 and held it in 14 quarters. The position peaked at $17.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Dimensional Fund Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 819,371 Day One Biopharmaceuticals shares in Q2 2026, an estimated $17.6M.
  • Dimensional Fund Advisors first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 14 quarters.
  • Dimensional Fund Advisors's Day One Biopharmaceuticals position peaked at $17.6M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.